CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. - Wikidata - awgldk - TriplyDB

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.

http://www.wikidata.org/entity/Q37358248

about

Epigenetic Alterations in Parathyroid Cancers The in vitro and vivo effects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target.CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma 5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma.Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.Understanding the genetic basis of parathyroid carcinoma.Clinicopathological correlates of hyperparathyroidism.Update on parathyroid carcinoma.Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours.The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features.A nonfunctioning parathyroid carcinoma misdiagnosed as a follicular thyroid nodule.Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome.The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy.Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.Expression, function, and regulation of the embryonic transcription factor TBX1 in parathyroid tumors.A nationwide study on parathyroid carcinoma.

P2860

Q30398206-BB21E737-EFC4-4C32-AD5C-07600406310D Q33618790-1F6E542A-EF52-4AEF-8ADC-BE78C9CDB5A5 Q34396517-29BEC74D-06A6-4F55-BB83-CA1ECE15BECF Q36680526-BBA32137-8F00-4FEC-BEE3-01687EBB43EB Q37378253-CE2DFC14-4A48-4B1F-8665-397CF7E1A41C Q38176824-7D34F45D-9741-4141-8EE4-8B437E2F94A9 Q38545172-3291120C-95C2-4B34-B4E1-1FB30FB4C641 Q38784218-875464FA-B6DB-4E38-A24A-10889FAC3D2C Q38806483-72E1439A-59A9-4DCE-8756-E32EEA19D8A1 Q38858757-6E5DC8D7-D70C-4144-926E-DC7B54A1258F Q42695925-8AD70820-5F50-40A5-BE7F-19727BA534E7 Q43157359-E59FE373-D4A4-43D6-BCF1-495D2B9174DF Q44004244-4A210A13-11FC-4F7A-8FC8-4146E5791D48 Q45879500-2DBB4A49-2BC7-4638-8AB0-C67E22D0011A Q45907440-330E48C0-B1D4-4F2E-9F5A-61FBD6FD94DB Q47664476-E4EF2C44-BC96-4C6F-A5A5-1218B6B9E331 Q52778896-28823960-AB80-4118-A4BD-6670CD95AC43

P2860

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.

http://www.wikidata.org/entity/Q37358248

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.

@en

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.

@nl

type

label

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.

@en

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.

@nl

prefLabel

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.

@en

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.

@nl

P1433

Q37358248-69A08158-ABC2-4FCD-A9CA-7E3ACFC793DB

P1476

Q37358248-2069286A-688A-4570-9A17-3B1CEBFFB3B5

P2093

Q37358248-12688585-DD37-497C-B76E-584256AFE7AE

Q37358248-36D974B8-A0B3-4087-BDA6-D3633B91212B

Q37358248-44D1EAFD-C796-4DB8-878B-03B674826324

Q37358248-464EB8EF-AA17-41C7-ADD9-FE5D92617FFE

Q37358248-699D6AF6-89BF-42C6-8808-60CDC554D7A0

Q37358248-77D2D036-6D14-4661-A0AA-8A02930EC1CA

Q37358248-954700A0-9D39-4FCE-8401-DF8F8A851CA4

Q37358248-AFB97686-B091-4EF1-8C81-CDB765A52826

Q37358248-BE19B2B0-EC15-4536-A114-EC76255E9505

Q37358248-C2911D2A-A4AA-4AC6-BC93-62D41BF9CA9B

P2860

Q37358248-133C5018-D602-4800-95F4-80C45B89FABC

Q37358248-2DC86ACD-38D9-41AF-B04C-B5C289FCC921

Q37358248-3B26D70F-10AA-49BB-BFC8-5B8F72E25302

Q37358248-3F0740B8-26C6-44B2-BC8F-E30DA0B0CE19

Q37358248-41B2D137-F7CC-4612-B844-723A0D3E085A

Q37358248-682A2F31-1397-41A9-9497-E88B7BE82DAF

Q37358248-740D3742-DD1C-4541-BED2-D31CF8DB9D91

Q37358248-76BF2760-34E8-4F40-A800-AF234BF14992

Q37358248-80AC847E-0042-4FC8-866D-F1F281C08E4B

Q37358248-862C8FDC-EF98-463D-9B48-D094F424D90D

P304

Q37358248-794160F1-C07B-4274-A5A0-12E9F6B7A4F9

P31

Q37358248-A8632004-3F58-45DE-A341-3D2A84261590

P356

Q37358248-644B98D0-EBC3-481B-A600-B6A2FF7EC078

P433

Q37358248-ACB3AF43-A938-4D1E-9BC3-C9C22D28D602

P478

Q37358248-19256B0B-6BCA-4A08-904C-27C41462665E

P50

Q37358248-315C5907-2503-45DE-A3AD-2A7768D81054

Q37358248-420D2556-CFB8-411F-A5CE-9554D8323EAA

Q37358248-5B9F4CF5-532F-41DD-879F-3A27851C9076

P577

Q37358248-380012D0-CA68-4401-B404-F0171EF7DF3A

P698

Q37358248-B9E51BD6-412B-4FCE-AD52-56DC46AD52AE

P932

Q37358248-D3867FC7-E4B5-491F-B9C1-A9B18265FCBF

P356

P1433

Endocrine connections

P1476

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer

@en

P2093

Chiara Banti

http://www.w3.org/2001/XMLSchema#string

Claudio Marcocci

http://www.w3.org/2001/XMLSchema#string

Edda Vignali

http://www.w3.org/2001/XMLSchema#string

Elena Pardi

http://www.w3.org/2001/XMLSchema#string

Federica Saponaro

http://www.w3.org/2001/XMLSchema#string

Filomena Cetani

http://www.w3.org/2001/XMLSchema#string

Guido Gasparri

http://www.w3.org/2001/XMLSchema#string

Liborio Torregrossa

http://www.w3.org/2001/XMLSchema#string

Maria Rosa Pelizzo

http://www.w3.org/2001/XMLSchema#string

Massimo Rugge

http://www.w3.org/2001/XMLSchema#string

P2860

HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours

Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society

Hyperparathyroid and hypoparathyroid disorders.

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.

Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.

Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics.

Novel HRPT2/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas

The DNA methylome of benign and malignant parathyroid tumors.

Parathyroid carcinoma: a 43-year outcome and survival analysis.

Clinical practice. Primary hyperparathyroidism.

P304

186-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/EC-13-0046

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Gianmaria Pennelli

P577

2013-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24145611

http://www.w3.org/2001/XMLSchema#string

P932

3847926

http://www.w3.org/2001/XMLSchema#string